With effect from the start of business on 25 April 2007, Exane Derivatives S.N.C ( "Exane" or "the firm") will become a member firm of the London Stock Exchange.
The firm will have no direct access to the Exchange's markets.
|Issued by: Client Implementation Team|
|Telephone: 020 7797 3232 or STX 33232|
|Issue date: 24 April 2007|
|Issue number: 2007/075|
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
You will be redirected in five seconds